Although the efficiency of the two GSK3β inhibitors (AR-A014418 and SB-216763) on several cellular processes was different, these inhibitors exerted the same pharmacological effect impairing the mitotic process of the respective colon cancer cell lines. This evidence concerns the gene GSK3B and colonic neoplasm.